图书馆主页
数据库简介
最新动态
联系我们



返回首页


字顺( Alphabetical List of Journals):

A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


检 索:        高级检索

期刊名称:VALUE IN HEALTH

ISSN:1098-3015
出版频率:Monthly
出版社:ELSEVIER SCIENCE INC, STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169
  出版社网址:http://www.blackwellpublishing.com/
期刊网址:http://www.blackwellpublishing.com/journal.asp?ref=1098-3015
影响因子: 5.728 (2020年) 5.037(2018年) 5.494(2017年) 4.235(2016年) 3.824(2015年) 3.279(2014年) 2.891(2013年) 2.191 (2012年) 2.191(2011年)
主题范畴:ECONOMICS;    HEALTH POLICY & SERVICES

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

Value in Health is a multidisciplinary peer-reviewed journal reporting on evaluations of medical technologies including pharmaceuticals, biologics, devices, procedures, and other health care interventions. It provides a scientific forum for communicating health economics and outcomes research methods and findings, furthering ISPOR's vision that "society allocate scarce health care resources wisely, fairly, and efficiently." It is also a sounding board for the discussion of health policy issues related to health economics and outcomes studies associated with all medical technologies.

 


Instructions to Authors

Value in Health is a peer-reviewed publication of the International Society for Pharmacoeconomics and Outcomes Research. Its mission is to provide a forum for the advancement and dissemination of knowledge and research in pharmacoeconomics and the health-related outcomes of disease and treatment processes. The journal therefore solicits original contributions in applied and theoretical pharmacoeconomics, and in the theory, measurement, and analysis of the health-related outcomes relevant to forwarding scholarly and public dialogue about the assessment of value in health and health care. In keeping with its broad mission, Value in Health will also accept methodology papers and critical reviews of empirical and theoretical literature in pharmacoeconomics and outcomes research.

VH does not consider papers reporting data series or data sets that do not include appropriate statistical confidence intervals and/or other measures of statistical imprecision. VH also does not consider papers reporting modeling results that do not include sensitivity analysis of key and influential model parameters.

Authors for whom English is a second language may choose to have their manuscript professionally edited before submission or during the review process. Authors wishing to pursue a professional English-language editing service should make contact and arrange payment with the editing service of their choice. For more details regarding the recommended services, please refer to http://www.blackwellpublishing.com/bauthor/english_language.asp

Manuscript Submission and Specifications
Authors should submit manuscripts electronically as email attachments wherever possible. Processing of a manuscript for peer review will begin only once a signed Copyright Transfer, Disclosure, and Acknowledgment form has been received for each author on the manuscript. (This form is available on the Value in Health page of the ISPOR Web site at
www.ispor.org. A faxed copy of this completed and signed form is acceptable; fax to 323-843-9900.)

If submissions sent by email are larger than 500 KB, they should be compressed using PKZIP or WINZIP. Regular mail or courier mail submissions should only be made when email submissions are not possible, and should include the document in electronic form on disk.

Authors will be required to assign copyright in their papers.  Copyright assignment is a condition of publication and papers will not be passed to the publisher for production unless copyright has been assigned.  An appropriate copyright assignment form can be found at the following address: VHE Copyright Assignment Form.

All submissions should be addressed to: Value in Health ISPOR, 3100 Princeton Pike, Suite 3E, Lawrenceville, NJ  08648 . Email: viheditor@ispor.org; fax 323-843-9900.

Cover Letter
The cover letter should include: 1) title of the manuscript; 2) name of the document file(s) containing the manuscript and the software (and version) used; 3) name and all contact information for the corresponding author and a statement as to whether the data, models, or methodology used in the research are proprietary; 4) names of all sponsors of the research and a statement of all direct or indirect financial relationships the authors have with the sponsors; and 5) if applicable, a statement that the publication of study results was not contingent on the sponsor's approval or censorship of the manuscript.

Manuscripts
Manuscripts must be written in English, typed in either Microsoft Word (Version 5.0 or later) or WordPerfect (version 5.1 or later). Manuscripts should be in 8.5x11-inch page format, double-spaced with 1-inch margins on all sides and size 10 font (Arial or Times New Roman fonts are preferred). Minimal formatting should be used, i.e., no justification, italics, bold, indenting, etc. There should be no hard returns at the end of lines. Double-spacing after each element is requested (e.g., headings, titles, paragraphs, legends). There is no limit on manuscript length, but length in terms of clarity and conciseness will be considered in the editorial process. The "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" should be consulted for specific style issues not addressed here (www.acponline.org, Ann Intern Med 1997;126:36-47).

Title Page
The title page should contain the following: 1) title; 2) full names (first and surname) of all authors including academic degrees and afffiliation(s); 3) name, mailing and email addresses, telephone and fax numbers of corresponding author (with whom all correspondence will take place unless other arrangements are made); 4) all sources of financial or other support for the manuscript (if no funding was received, this should be noted on the title page); 5) at least four key words for indexing purposes; and 6) a running title of not more than 45 characters including spaces.

Abstract
An abstract of 250 words or less is required, summarizing the work reported in the manuscript. Original research manuscripts should use a structured format for the abstract, i.e., Objectives, Methods, Results, Conclusions.

Text
The body of the manuscript should be divided into sections that facilitate reading and comprehension of the material. This should normally include sections with the major headings: Introduction, Methods, Results, Conclusions, Acknowledgments (if needed), References, Figure Legends, Figures, and Tables. There should be no footnotes. References must be numbered with Arabic numerals in square brackets in the text (not superscript), and listed in the reference section in the order in which they are cited. Tables and figures must be cited in the text, and numbered in Arabic numerals in the order in which they are cited. Equations should be presented on separate lines and cited by Arabic numeral in parentheses at the left-hand margin.

Tables and Figures
Tables and figures should be clearly labelled and easy to understand without reference to the text. Tables should be double-spaced and each should be presented on a separate page. Statistical estimates should indicate parameter estimates and, as appropriate, t ratios or standard error, statistical significance, sample size, and other relevant information. All abbreviations must be explained below each table. Each table should be numbered and have a self-explanatory title. All illustrations should be reducible by 50-66% of original size without loss of legibility. There will be a charge to the author for printing color illustrations. Each figure must have a corresponding legend, typed double-spaced on a separate page. Each figure must be numbered with an Arabic numeral, and all symbols, arrows, and abbreviations must be explained in the legend. Previously published figures must be accompanied by written authorization for their use and the original source must be named in the legend. For information about digitally submitted graphics, please contact the editorial office (
viheditor@ispor.org).

We are happy to receive your artwork in digital format. Please save line artwork (vector graphics) as Encapsulated PostScipt  (EPS) and bitmat files (halftones or photographic images) as Tagged Image Format (TIFF), with a resolution of at least 300 dpi at final size. Do not send native file formats. More detailed information can be found on the submission of electronic artwork at http://www.blackwell-science.com/elecmed/digill.htm

References
References should be listed in a separate section and numbered consecutively with Arabic numerals in the order in which they are cited in the text. Citing unpublished or non-peer-reviewed work such as abstracts and presented papers is discouraged. Personal communications may be indicated in the text as long as written acknowledgment from the authors of the communications accompanies the manuscript. Reference style should follow that of Index Medicus. Spell out single-word journals and abbreviate all others according to the style of Index Medicus. If there are more than four authors, use only the names of the first three, followed by et al. The three most common types of references are illustrated below for example.

Journal article: Surname and initials of author(s), title of article, name of journal, year, volume number, first and last page.
Arocho R, McMillan CA. Discriminant and criterion evaluation of the U.S.-Spanish version of the SF-36 Health Survey in a Cuban-American population with benign hyperplasia. Med Care 1998;36:766-72.

Book: Surname and initials of author(s)/editor(s), title and subtitle, volume, edition (other than first), city, publisher, year.
Johnston J. Econometric Methods (3rd ed.). New York: McGraw-Hill, 1984.

Chapter in Book: Surname and initials of author(s), title of chapter, author(s)/editor(s) of book, title of book, volume, edition (other than first), city, publisher, year.
Luce BR, Manning WG, Siegel JE, et al. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, et al., eds., Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996.

Data, Models, and Methodology
All authors must agree to make their data available at the Editor's request for examination and re-analysis by referees or other persons designated by the Editor. All models and methodologies must be presented in sufficient detail to be fully comprehensible to readers.

Author Anonymity
From September 15, 2003, it is the policy of Value in Health that peer review of submitted manuscripts is double blinded, i.e., the reviewers do not know the names of the authors of manuscripts and the authors do not know the names of the reviewers.  Blinded reviews are common practice at many important scientific and medical journals.  The Value in Health editorial office will remove all authors names before the paper is sent out for peer review.

The Review Process
All manuscripts deemed appropriate for Value in Health after initial screening will be reviewed by at least two peer reviewers. The objective of the journal is to complete peer review and reach editorial decision within ten to twelve weeks of submission, at which time the corresponding author will receive written notification, including anonymous reviewer commentary.

NEW: Online production tracking is now available for your article through Blackwell's Author Services.
Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit
www.blackwellpublishing.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

 


Editorial Board

Editor-in-Chief
Josephine Mauskopf,
PhD
RTI Health Solutions
RTI International
Research Triangle Park
, NC

jmauskopf@rti.org

Editorial Office
ISPOR
3100 Princeton Pike, Suite 3E
Lawrenceville, NJ 08648
viheditor@ispor.org

Managing Editor
Stephen Priori
spriori@ispor.org

Co-Editors
Richard J. Milne, PhD
rj.milne@auckland.ac.nz

John Hornberger, MD, MS
jhornberger@sphereinstute.org

C. Daniel Mullins, PhD
dmullins@rx.umaryland.edu

Michelle Naughton, PhD
naughton@wfubmc.edu

Sean Sullivan, PhD
sdsull@u.washington.edu

Johan L. Severens, PhD
h.severens@beoz.unimaas.nl

Andrew Briggs, BA, MSc, DPhil
a.briggs@clinmed.gla.ac.uk

William R. Lenderking, PhD
william_r_lenderking@pfizer.com

Gordon G. Liu, PhD
ggliu@unc.edu

Adrian Levy, PhD
alevy@interchange.ubc.ca

Martin Backhouse, Dr PH
martin.backhouse@novartis.com

Chris Bingefors, PhD, MSc
chris.bingefors@farmaci.uu.se

Editorial Office
Danielle Mroz
dmroz@ispor.org

Management Advisory Board

Joyce Cramer
Yale University School of Medicine
New Haven, CT
joyce.cramer@yale.edu

Scott Ramsey, PhD, MD
Fred Hutchinson Cancer Research Center
Seattle, WA
sramsey@fhcrc.org

Adrian Towse, MPhil
Office of Health Economics
London, UK
atowse@ohe.org

Editorial Advisory Board
Marc L. Berger, MD
Merck & Company, Inc.
West Point, PA
marc_berger@merck.com

J. Lyle Bootman, PhD
University of Arizona
Tucson, AZ
bootman@pharmacy.arizona.edu

John Cairns, MD
University of Aberdeen
Aberdeen, Scotland, UK
jcairns@abdn.ac.uk

Jonathan Cooke, MD, FRCP
South Manchester University Hospitals
Manchester, UK
jonathan.cooke@man.ac.uk

Pete Fullerton, PhD
University of Washington
Seattle, WA
peteful@msn.com

Jean Paul Gagnon, PhD
Aventis Pharmaceuticals Inc.
Parsippany, NJ
jean.gagnon@sanofi-aventis.com

Henry Glick
University of Pennsylvania
Philadelphia, PA
hlthsvrs@mail.med.upenn.edu

Timothy R. Hylan, PhD
Pfizer
New York, NY
timothy.hylan@pfizer.com

Nelda Johnson, PharmD
Outcomes Research & Design Inc.
Lincoln Springs, OR
neldajohnson@mindspring.com

Paul Kind, MPhil
Centre for Health Economics
University of York
York, UK
pk1@york.ac.uk

Paul C. Langley, PhD
University of Minnesota
Woodbury, MN
P8366@MSN.com

Pablo Lapuerta, MD
Bristol-Myers Squibb
Princeton, NJ
lapuertp@bms.com

Karl W. Lauterbach, MD, ScD
University of Cologne
Cologne, Germany
lauterigmg@t-online.de

Steven E. Marx, PharmD, MS
Abbott Laboratories
Abbott Park
, IL

steve.marx@abbott.com

Karl A. Matuszewski, MS, PharmD
Univ Health System Consortium
Oak Brook, IL
matuszewski@uhc.edu

William F. McGhan, PharmD, PhD
University of the Sciences in Philadelphia
Philadelphia, PA
w.mcghan@usip.edu

Louis A. Morris, PhD
Louis A. Morris & Assoc.
Dix Hills, NY
lmorris@optonline.net

Alan Mutnick, PharmD
University of Virginia Health System
Charlottesville, VA
ahm3p@hscmail.mcc.virginia.edu

Peter J. Neumann, SciD
Tufts--New England Medical School
Boston, MA
pneumann@tufts-nemc-org

Mark Nuijten, PhD, MD, MBA
MEDTAP
Jisp, The Netherlands
marknuiten@planet.nl

Fredrick K. Orkin, MD, MBA
Penn State University
Hershey, PA
frederickorkin@yahoo.com

Nicolaas Otten, PharmD
Ottawa, Ontario, Canada
nicolaaso@home.com

A. David Paltiel, PhD
Yale University
New Haven, CT
david.paltiel@yale.edu

Chris L. Pashos, PhD
Abt-associates HERQuLES
Cambridge, MA
chris_pashos@abtassoc.com

Dennis Revicki, PhD
MEDTAP International
Bethesda, MD
dennis.Revicki@unitedbiosource.com

Kevin A. Schulman, MD
Duke University
Durham, NC
schul012@mc.duke.edu

Jonathan Seltzer, MD, MBA
Applied Clinical Intellegence, LLC
Bala Cynwyd, PA
jseltzer@a-ci.com

Hugh H. Tilson, MD, DrPH
University of North Carolina at Chapel Hill
Chapel Hill, NC
hugh_tilson@unc.edu

George W. Torrance, PhD
Innovus Research Inc.
Burlington, Ontario, Canada
gtorrance@innovus.com

Scott Weingarten, MD, MPH
Zynx Health
Los Angeles, CA
weingarten@zynx.com

Milton C. Weinstein, PhD
Harvard School of Public Health
Boston, MA
mcw@hsph.harvard.edu



 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2008 武汉大学图书馆版权所有